Zusammenfassung
Bei internistischen Patienten sind unerwünschte Arzneimittelereignisse häufig. Viele solche Ereignisse sind allerdings vermeidbar, da sie durch Medikationsfehler verursacht werden. Diese treten besonders häufig bei der Arzneimittelverordnung auf. Es bedarf deshalb praxisnaher Konzepte, um das wachsende Wissen zu Arzneimitteln beim Verordnungsprozess verfügbar zu machen. Aber auch wenn Abweichungen vom Standard beabsichtigt sind, muss schnell auf aktuelle Informationen zugegriffen werden können. Computerbasierte Systeme können zu all diesen Anforderungen eine Unterstützung in der Arzneimittelverschreibung für den Arzt leisten und so die Qualität der Pharmakotherapie verbessern. Dazu müssen solche Systeme allerdings untereinander und sektorenübergreifend vernetzt sein, auf wissenschaftlichen Daten basieren und möglichst viele Faktoren für eine patientenindividuelle Therapie berücksichtigen. Die Individualisierung und Fokussierung auf die relevanten Informationen sind besonders wichtige Charakteristika, um unzutreffende Warnhinweise (Overalerting) zu verhindern und damit die Akzeptanz in der praktischen Nutzung zu erhöhen.
Abstract
Patients in internal medicine frequently experience adverse drug events. Many of those events, however, are avoidable because they are caused by medication errors, which are particularly frequent in drug prescribing. Therefore, practical concepts are needed to make the rapidly growing knowledge on drugs available already during prescription. But also when deviations from standards are intended access to up-to-date information is required. Computer-based systems can offer support for prescribing clinicians to meet these claims and thus improve the quality of pharmacotherapy. To reach this goal, such systems have to be interlinked among each other and with systems of primary, secondary, and tertiary care. They must be based on scientific published evidence and should consider as many factors as possible for individualization of drug therapy. Individualization and focusing on relevant information are prerequisites to prevent inappropriate alerts (over-alerting) and thus to increase acceptance in practical use.
Literatur
Abteilung Innere Medizin VI, Klinische Pharmakologie und Pharmakoepidemiologie, Universitätsklinikum Heidelberg, Dosisanpassung bei Niereninsuffizienz. http://www.dosing.de
American Hospital Association, American Society of Health-System Pharmacists, Hospitals & Health Networks (2005) Medication safety issue brief, Look-alike, sound-alike drugs. Hosp Health Netw 79: 57–58
Bates DW, Cullen DJ, Laird N et al. (1995) Incidence of adverse drug events and potential adverse drug events. Implications for prevention. JAMA 274: 29–34
Bates DW, Leape LL, Cullen DJ et al. (1998) Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 280: 1311–1316
Bates DW, Spell N, Cullen DJ et al. (1997) The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 277: 307–311
Bates DW, Teich JM, Lee J et al. (1999) The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc 6: 313–321
Bergk V, Gasse C, Schnell R, Haefeli WE (2004) Requirements for a successful implementation of drug interaction information systems in general practice: Results of a questionnaire survey in Germany. Eur J Clin Pharmacol 60: 595–602
Bergk V, Haefeli WE, Gasse C et al. (2005) Information deficits in the summary of product characteristics preclude an optimal management of drug interactions: A comparison with evidence from the literature. Eur J Clin Pharmacol 61: 327–335
Bertsche T, Fleischer M, Pfaff J et al. (2009) Pro-active provision of drug information as a technique to address overdosing in intensive-care patients with renal insufficiency. Eur J Clin Pharmacol [Epub ahead of print]
Bertsche T, Mayer Y, Stahl R et al. (2008) Prevention of intravenous drug incompatibilities in an intensive care unit. Am J Health Syst Pharm 65: 1834–1840
Bertsche T, Münk L, Mayer Y et al. (2009) Sustained effect of implementation of a standard operation procedure to prevent intravenous drug incompatibilities in an intensive care unit after one year. Am J Health Syst Pharm (in press)
Bertsche T, Walk SU, Kaltschmidt J et al. (2008) Arzneimitteltherapie an intersektoralen Schnittstellen - Lösungsstrategien zur Qualitätssicherung. Krankenhauspharmazie 29: 163–166
Bond CA, Raehl CL, Franke T (2000) Clinical pharmacy services, pharmacy staffing, and the total cost of care in United States hospitals. Pharmacotherapy 20: 609–621
Bond CA, Raehl CL, Pitterle ME, Franke T (1999) Health care professional staffing, hospital characteristics, and hospital mortality rates. Pharmacotherapy 19: 130–138
Chertow GM, Lee J, Kuperman GJ et al. (2001) Guided medication dosing for inpatients with renal insufficiency. JAMA 286: 2839–2844
Classen DC, Pestotnik SL, Evans RC et al. (1997) Adverse drug events in hospitalized patients. Excess length of stay, extra costs and attributable mortality. JAMA 277: 301–306
Classen DC, Pestotnik SL, Evans RS, Burke JP (1991) Computerized surveillance of adverse drug events in hospital patients. JAMA 266: 2847–2851
Cullen DJ, Sweitzer BJ, Bates DW et al. (1997) Preventable adverse drug events in hospitalized patients: A comparative study of intensive care and general care units. Crit Care Med 25: 1289–1297
Dartnell JG, Anderson RP, Chohan V et al. (1996) Hospitalisation for adverse events related to drug therapy: Incidence, avoidability and costs. Med J Aust 164: 659–662
Davidsen F, Haghfelt T, Gram LF, Brosen K (1988) Adverse drug reactions and drug non-compliance as primary causes of admission to a cardiology department. Eur J Clin Pharmacol 34: 83–86
Einarson TR (1993) Drug related hospital admissions. Ann Pharmacother 27: 832–840
Evans RS, Pestotnik SL, Classen DC et al. (1998) A computer-assisted management program for antibiotics and other antiinfective agents. N Engl J Med 338: 232–238
Falconnier AD, Haefeli WE, Schoenenberger RA et al. (2001) Drug dosage in patients with renal failure optimized by immediate concurrent feedback. J Gen Intern Med 16: 369–375
Ferner RE, Aronson JK (2000) Medication errors, worse than a crime. Lancet 355: 947–948
Ferner RE, Aronson JK (2006) Clarification of terminology in medication errors: Definitions and classification. Drug Saf 29: 1011–1022
Garg AX, Adhikari NK, McDonald H et al. (2005) Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: A systematic review. JAMA 293: 1223–1238
Greenhalgh T, Hughes J, Humphrey C et al. (2002) A comparative case study of two models of a clinical informaticist service. BMJ 324: 524–529
Han YY, Carcillo JA, Venkataraman ST et al. (2005) Unexpected increased mortality after implementation of a commercially sold computerized physician order entry system. Pediatrics 16: 1506–1512
Horlen C, Malone R, Bryant B et al. (2002) Frequency of inappropriate metformin prescriptions. JAMA 287: 2504–2505
Janchawee B, Wongpoowarak W, Owatranporn T, Chongsuvivatwong V (2005) Pharmacoepidemiologic study of potential drug interactions in outpatients of a university hospital in Thailand. J Clin Pharm Ther 30: 13–20
Knaup P, Pilz J, Kaltschmidt J et al. (2006) Standardized documentation of drug recommendations in discharge letters: A contribution to quality management in cooperative care. Methods Inf Med 45: 336–342
Kohler GI, Bode-Boeger SM, Busse R et al. (2000) Drug-drug interactions in medical patients: Effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther 38: 504–513
Koppel R, Metlay JP, Cohen A et al. (2005) Role of computerized physician order entry systems in facilitating medication errors. JAMA 293: 1197–1203
Leape LL, Cullen DJ, Clapp MD et al. (1999) Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 282: 267–270
Linnarsson R (1993) Drug interactions in primary health care. A retrospective database study and its implications for the design of a computerized decision support system. Scand J Prim Health Care 11: 181–186
Martin-Facklam M, Rengelshausen J, Tayrouz Y et al. (2005) Dose individualisation in patients with renal insufficiency: Does drug labelling support optimal management? Eur J Clin Pharmacol 60: 807–811
McCoy LK (2005) Look-alike, sound-alike drugs review: Include look-alike packaging as an additional safety check. Jt Comm J Qual Patient Saf 31: 47–53
Nebeker JR, Hoffman JM, Weir CR et al. (2005) High rates of adverse drug events in a highly computerized hospital. Arch Intern Med 165: 1111–1116
Nelson KM, Talbert RL (1996) Drug related hospital admissions. Pharmacotherapy 16: 701–707
Pargeon KL, Hailey BJ (1999) Barriers to effective cancer pain management: A review of the literature. J Pain Symptom Manage 18: 358–368
Pestotnik SL, Classen DC, Evans RS et al. (1993) Prospective surveillance of imipenem/cilastatin use and associated seizures using a hospital information system. Ann Pharmacother 27: 497–501
Quinzler R, Gasse C, Schneider A et al. (2006) The frequency of inappropriate pill splitting in primary care. Eur J Clin Pharmacol 62: 1065–1073
Raschetti R, Morgutti M, Menniti-Ippolito F et al. (1999) Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol 54: 959–963
Raschke RA, Gollihare B, Wunderlich TA, Guidry JR et al. (1998) A computer alert system to prevent injury from adverse drug events: Development and evaluation in a community teaching hospital. JAMA 280: 1317–1320
Rivkin A (2007) Admissions to a medical intensive care unit related to adverse drug reactions. Am J Health Syst Pharm 64: 1840–1843
Salomon L, Deray G, Jaudon MC et al. (2003) Medication misuse in hospitalized patients with renal impairment. Int J Qual Health Care 15: 331–335
Schneeweiss S, Hasford J, Gottler M et al. (2002) Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: A longitudinal population-based study. Eur J Clin Pharmacol 58: 285–291
Schulmeister L (2006) Look-alike, sound-alike oncology medications. Clin J Oncol Nurs 10: 35–41
Walk SU, Bertsche T, Kaltschmidt J et al. (2008) Rule-based standardised switching of drugs at the interface between primary and tertiary care. Eur J Clin Pharmacol 64: 319–327
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bertsche, T., Kaltschmidt, J. & Haefeli, W. Patientensicherheit durch computerbasierte Arzneimittelinformationen. Internist 50, 748–756 (2009). https://doi.org/10.1007/s00108-009-2398-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00108-009-2398-7
Schlüsselwörter
- Computerunterstützte Arzneimitteltherapie
- Arzneimittelverschreibung
- Dosisberechnung
- Arzneimittelinteraktionen
- Nierenfunktionsstörung